BTIG Maintains Buy on Medtronic, Raises Price Target to $100
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsPrice TargetHot
BTIG analyst Ryan Zimmerman maintains Medtronic (NYSE:MDT) with a Buy and raises the price target from $91 to $100.
BTIG analyst Ryan Zimmerman maintains Medtronic (NYSE:MDT) with a Buy and raises the price target from $91 to $100.